BEGIN:VCALENDAR
CALSCALE:GREGORIAN
VERSION:2.0
METHOD:PUBLISH
PRODID:explore_courses
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
X-LIC-LOCATION:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTEND;TZID=America/Los_Angeles:20170405T192000
LAST-MODIFIED:20170211T124036
UID:explore_coursesd71f1ee4-e3fd-4638-af95-5bf7d126649a
DTSTAMP:20170211T124036
LOCATION:
DESCRIPTION:(Continuation of 240A) Advancing a drug from discovery of a therapeutic target to human trials and commercialization. Topics include: high throughput assay development, compound screening, lead optimization, protecting intellectual property, toxicology testing, regulatory issues, assessment of clinical need, defining the market, conducting clinical trials, project management, and commercialization issues, including approach to licensing and raising capital. Maximum units are available by taking an additional contact hour. Prerequisite: 240A.
STATUS:CONFIRMED
SEQUENCE:0
SUMMARY:CSB240B LEC
DTSTART;TZID=America/Los_Angeles:20170405T173000
CREATED:20170211T124036
RRULE:FREQ=WEEKLY;INTERVAL=1;UNTIL=20170607T192000;BYDAY=WE
END:VEVENT
END:VCALENDAR